Healthcare

SINGAPORE (Feb 10): CIMB Research is highlighting its most preferred stocks from various sectors which it thinks could benefit from the strategies set by the Singapore government for the long term, following yesterday’s release of the long-awaited Commi

SINGAPORE (Feb 1): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will hold its official opening ceremony on Feb 22 at its office located at Launchpad @One North.

SINGAPORE (Jan 16): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will receive a grant of up to $2.2 million under SPRING Singapore’s Incubator Development Program.

BEIJING (Jan 6): The thick haze of pollution blanketing northern China this winter is a grim reminder of the nation’s new growth industry: lung cancer drugs.

SINGAPORE (Jan 4): RHB Research has reiterated its “overweight” rating on the healthcare sector, as the ageing population trend continues.

SINGAPORE (Dec 29): Swiss global financial services company UBS is staying positive on US and emerging market (EM) equities in the year ahead.

SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.

SINGAPORE (Nov 25): If Fullerton’s IPO had gone ahead, it would have been one of the largest of the year. And, with an expected market value of more than $1.1 billion, it would have been a welcome addition to the burgeoning cluster of healthcare plays i

SINGAPORE (Nov 21): Fullerton Health says it has deferred its plans to launch an initial public offering (IPO) in 2016 due to “current market uncertainty”.

SINGAPORE (Nov 11): Haw Par Corporation has posted 3Q16 earnings of $42.4 million, up 21.3% from $34.9 million a year ago due to higher gross margins and absence of one-off loss on disposal of available-for-sale financial assets in prior year.